Kiniksa Pharmaceuticals International Plc (KNSA)

43.31 +0.55 (+1.29%) USD  |  NASDAQ  |  Feb 26, 12:49
More

Kiniksa Pharmaceuticals International Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for KNSA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
NovoCure Ltd. Upgrade
LivaNova Plc Upgrade
ADMA Biologics, Inc. Upgrade
Alterola Biotech, Inc. Upgrade